NRobe®

The NRobe system is a patent pending* technology comprising a process, equipment and films to produce dosage forms.  The drug-loaded fill is lightly compressed and enrobed between two dry, pre-formed films and sealed to provide a non-friable, coated dosage form.

Potential benefits of NRobe include:

  • Elegant presentation of compression-sensitive or moisture
  • sensitive formulations
  • Improved dissolution versus conventional oral dosage forms
  • Reduced dependence on problematic excipients
  • Reduced formulation time
  • Improved manufacturing efficiencies, all-in-one process

NRobe technology may be utilized for many applications in dose form formulation including:
(click an application below to view a bulletin)



*FMC acquired an exclusive, worldwide license of NRobe technology from BioProgress plc in February 2004.


Magenta
Terms & Conditions Privacy Statement
Login